108 related articles for article (PubMed ID: 17191150)
1. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry.
Leiva LE; Zelazco M; Oleastro M; Carneiro-Sampaio M; Condino-Neto A; Costa-Carvalho BT; Grumach AS; Quezada A; Patiño P; Franco JL; Porras O; Rodríguez FJ; Espinosa-Rosales FJ; Espinosa-Padilla SE; Almillategui D; Martínez C; Tafur JR; Valentín M; Benarroch L; Barroso R; Sorensen RU;
J Clin Immunol; 2007 Jan; 27(1):101-8. PubMed ID: 17191150
[TBL] [Abstract][Full Text] [Related]
2. Off-premises demand elasticities for pure alcohol in five Latin American countries: The case of Argentina, Chile, Costa Rica, Honduras, and Uruguay.
Paraje G; Araya D; Monteiro M
Int J Drug Policy; 2024 Feb; 124():104316. PubMed ID: 38219676
[TBL] [Abstract][Full Text] [Related]
3. Types of Psychiatric Beds and Mental Health Services in 16 Latin American Countries, 1990-2020.
Mundt AP; Delhey S; Martínez P; Irarrázaval M; Grasso L; Rivera-Arroyo G; Capistrano A; Trujillo N; Golcher F; Benavides Salcedo A; Dedik C; Cordero M; Torales J; Malpartida C; Almánzar Á
Psychiatr Serv; 2024 Jan; 75(1):48-54. PubMed ID: 37644830
[TBL] [Abstract][Full Text] [Related]
4. The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative.
Bessone F; Hernandez N; Lucena MI; Andrade RJ;
Int J Mol Sci; 2016 Feb; 17(3):313. PubMed ID: 26938524
[TBL] [Abstract][Full Text] [Related]
5. Publisher Correction: cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru.
Augustovski F; Bardach A; Santoro A; Rodriguez-Cairoli F; López-Osornio A; Argento F; Havela M; Blumenfeld A; Ballivian J; Solioz G; Capula A; López A; Cejas C; Savedoff W; Palacios A; Rubinstein A; Pichon-Riviere A
Cost Eff Resour Alloc; 2023 Aug; 21(1):56. PubMed ID: 37620882
[No Abstract] [Full Text] [Related]
6. Ataxia-telangiectasia in Latin America: clinical features, immunodeficiency, and mortality in a multicenter study.
Pereira RA; Dantas EO; Loekmanwidjaja J; Mazzucchelli JTL; Aranda CS; Serrano MEG; De La Cruz Córdoba EA; Bezrodnik L; Moreira I; Ferreira JFS; Dantas VM; Sales VSF; Fernandez CC; Vilela MMS; Motta IP; Franco JL; Arango JCO; Álvarez-Álvarez JA; Cardozo LRR; Orellana JC; Condino-Neto A; Kokron CM; Barros MT; Regairaz L; Cabanillas D; Suarez CLN; Rosario NA; Chong-Neto HJ; Takano OA; Nadaf MISV; Moraes LSL; Tavares FS; Rabelo F; Pino J; Calderon WC; Mendoza-Quispe D; Goudouris ES; Patiño V; Montenegro C; Souza MS; Branco AB; Forte WCN; Carvalho FAA; Segundo G; Cheik MFA; Roxo-Junior P; Peres M; Oliveira AM; Neto ACP; Ortega-López MC; Lozano A; Lozano NA; Nieto LH; Grumach AS; Costa DC; Antunes NMN; Nudelman V; Pereira CTM; Martinez MDM; Quiroz FJR; Cardona AA; Nuñez-Nuñez ME; Rodriguez JA; Cuellar CM; Vijoditz G; Bichuetti-Silva DC; Prando CCM; Amantéa SL; Costa-Carvalho BT
Immunol Res; 2024 Jun; ():. PubMed ID: 38834764
[TBL] [Abstract][Full Text] [Related]
7. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012.
Edgar JD; Buckland M; Guzman D; Conlon NP; Knerr V; Bangs C; Reiser V; Panahloo Z; Workman S; Slatter M; Gennery AR; Davies EG; Allwood Z; Arkwright PD; Helbert M; Longhurst HJ; Grigoriadou S; Devlin LA; Huissoon A; Krishna MT; Hackett S; Kumararatne DS; Condliffe AM; Baxendale H; Henderson K; Bethune C; Symons C; Wood P; Ford K; Patel S; Jain R; Jolles S; El-Shanawany T; Alachkar H; Herwadkar A; Sargur R; Shrimpton A; Hayman G; Abuzakouk M; Spickett G; Darroch CJ; Paulus S; Marshall SE; McDermott EM; Heath PT; Herriot R; Noorani S; Turner M; Khan S; Grimbacher B
Clin Exp Immunol; 2014 Jan; 175(1):68-78. PubMed ID: 23841717
[TBL] [Abstract][Full Text] [Related]
8. Difficult Cases in Primary Immunodeficiency.
Izadi N; Sullivan KE
J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3559-3560.e9. PubMed ID: 37945212
[No Abstract] [Full Text] [Related]
9. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015.
Picard C; Al-Herz W; Bousfiha A; Casanova JL; Chatila T; Conley ME; Cunningham-Rundles C; Etzioni A; Holland SM; Klein C; Nonoyama S; Ochs HD; Oksenhendler E; Puck JM; Sullivan KE; Tang ML; Franco JL; Gaspar HB
J Clin Immunol; 2015 Nov; 35(8):696-726. PubMed ID: 26482257
[TBL] [Abstract][Full Text] [Related]
10. The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies.
Bousfiha A; Jeddane L; Al-Herz W; Ailal F; Casanova JL; Chatila T; Conley ME; Cunningham-Rundles C; Etzioni A; Franco JL; Gaspar HB; Holland SM; Klein C; Nonoyama S; Ochs HD; Oksenhendler E; Picard C; Puck JM; Sullivan KE; Tang ML
J Clin Immunol; 2015 Nov; 35(8):727-38. PubMed ID: 26445875
[TBL] [Abstract][Full Text] [Related]
11. Primary immunodeficiency diseases worldwide: more common than generally thought.
Bousfiha AA; Jeddane L; Ailal F; Benhsaien I; Mahlaoui N; Casanova JL; Abel L
J Clin Immunol; 2013 Jan; 33(1):1-7. PubMed ID: 22847546
[TBL] [Abstract][Full Text] [Related]
12. [Registry of primary immunodeficiencies in children at a fourth level hospital. Bogota, 2010-2016].
Pedraza Á; Vargas-Rumilla MI; Ramírez-Roa JL
Rev Alerg Mex; 2018; 65(4):341-348. PubMed ID: 30602203
[TBL] [Abstract][Full Text] [Related]
13. Skin disorders are prominent features in primary immunodeficiency diseases: A systematic overview of current data.
de Wit J; Brada RJK; van Veldhuizen J; Dalm VASH; Pasmans SGMA
Allergy; 2019 Mar; 74(3):464-482. PubMed ID: 30480813
[TBL] [Abstract][Full Text] [Related]
14. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes.
Modell V; Orange JS; Quinn J; Modell F
Immunol Res; 2018 Jun; 66(3):367-380. PubMed ID: 29744770
[TBL] [Abstract][Full Text] [Related]
15. Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID).
Condino-Neto A; Sorensen RU; Gómez Raccio AC; King A; Espinosa-Rosales FJ; Franco JL
Allergol Immunopathol (Madr); 2015; 43(5):493-7. PubMed ID: 25294607
[TBL] [Abstract][Full Text] [Related]
16. Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases.
Zelazko M; Carneiro-Sampaio M; Cornejo de Luigi M; Garcia de Olarte D; Porras Madrigal O; Berrón Perez R; Cabello A; Rostan MV; Sorensen RU
J Clin Immunol; 1998 Mar; 18(2):161-6. PubMed ID: 9533660
[TBL] [Abstract][Full Text] [Related]
17. Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients.
Gul I; Khan TA; Akbar NU; Gul N; Ali R; Khan SN
Ital J Pediatr; 2023 Aug; 49(1):95. PubMed ID: 37533075
[TBL] [Abstract][Full Text] [Related]
18. Immunodeficiency Hiding in Plain Sight.
Argyle TC; Singh A; Abdullah F
Cureus; 2022 Aug; 14(8):e27571. PubMed ID: 35928175
[TBL] [Abstract][Full Text] [Related]
19. The Primary Immunodeficiency Database in Japan.
Mitsui-Sekinaka K; Sekinaka Y; Endo A; Imai K; Nonoyama S
Front Immunol; 2021; 12():805766. PubMed ID: 35082792
[TBL] [Abstract][Full Text] [Related]
20. Trends in Pediatric Primary Immunodeficiency: Incidence, Utilization, Transplantation, and Mortality.
Eddens T; Mack M; McCormick M; Chong H; Kalpatthi R
J Allergy Clin Immunol Pract; 2022 Jan; 10(1):286-296.e3. PubMed ID: 34718217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
